Intellia Therapeutics

NTLA · NASDAQ

$11.84+$0.26 (+2.25%)TodayMarket closed ·
Prev close $11.58

Who owns NTLA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 53.4% of NTLA’s shares.

  • ARK Investment Management LLC12.1%
  • BlackRock Institutional Trust Company, N.A.7.9%
  • State Street Investment Management (US)6.6%
  • Vanguard Portfolio Management, LLC5.2%
  • Next 6 largest institutions21.5%
  • All other shareholders46.6%
Top institutional holders of NTLA
HolderShares% of shares
ARK Investment Management LLC16.88M12.08%
BlackRock Institutional Trust Company, N.A.11.09M7.93%
State Street Investment Management (US)9.23M6.61%
Vanguard Portfolio Management, LLC7.33M5.25%
D. E. Shaw & Co., L.P.6.44M4.61%
Vanguard Capital Management, LLC6.03M4.31%
Two Sigma Investments, LP5.25M3.76%
RA Capital Management, LP4.53M3.24%
Fidelity Management & Research Company LLC4.11M2.94%
Regeneron Pharmaceuticals, Inc.3.70M2.65%

Largest mutual fund holders

Top mutual fund holders of NTLA
HolderShares% of shares
ARK Innovation ETF9.61M6.88%
State Street SPDR S&P Biotech ETF6.06M4.34%
Vanguard Total Stock Market Index Fund4.30M3.08%
iShares Russell 2000 ETF3.51M2.51%
Vanguard Small-Cap Index Fund3.12M2.23%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $529.74K (6 trades) of NTLA on the open market, with no buys.

Latest NTLA insider transactions
InsiderTypeSharesValue
Dube Michael PSale1.86K$23.17K
LEONARD JOHN MSale2.79K$36.20K
LEONARD JOHN MSale19.89K$250.61K
Dulac Edward J IIISale8.11K$91.25K
Dulac Edward J IIISale4.68K$84.19K
Dube Michael PSale2.64K$44.32K
GOODMAN JESSEAward13.30K—
GOODMAN JESSEAward9.20K—
Keresty GeorgiaAward13.30K—
Keresty GeorgiaAward9.20K—

Short interest

Settled Sep 30, 2026

Shares short
45.11M
Days to cover
9.47
% of shares outstanding
32.29%
Average daily volume
4.77M
Change since last report
−3.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.